> Quest Diagnostics has acquired Sweden's HemoCue, from the private equity firm EQT II for $420 million in cash. Release
> Affymax has nailed a $10 million milestone payment from Takeda. Release
> The FDA has called MGI Pharma's ad for a brain cancer drug "misleading." Report
> Pozen says it will file a response to the FDA on its Trexima migraine therapy in a few days. Report
> Aastrom has received an orphan drug designation for its Tissue Repair Cells used in chronic heart disease. Release
> Targacept is expanding its lab and office space in the Piedmont Triad Research Park. Release
> Generex is launching a Phase II trial for a breast cancer therapy. Release
> Heart muscle created from embryonic stem cells. Report
> New allergy vaccine works in a matter of weeks. Report
And Finally… A major new study concludes that fine grit in the air is a serious health threat to women, raising the risk of cardiovascular disease. Article